(Q51477941)

English

Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.

scientific article published in March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

type 2 diabetes

0 references

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Hedblad B

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Zambanini A

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Nilsson P

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Janzon L

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Berglund G

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

261

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

293-305

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01767.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2007.01767.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17305652

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51477941&oldid=1538926993"